Scientific Resources

Our next-generation diagnostic assays have generated novel insights across a broad range of clinical applications.

Access our presentations, publications, and more to see how we’re unlocking the full potential of precision genomics.

Remission Assessment by Circulating Tumor DNA in Large B-cell Lymphoma
August 26, 2025 | Manuscript
Prognostic value of circulating tumor DNA (ctDNA) detection by PhasED-Seq after axicabtagene ciloleucel therapy in relapsed/refractory large B-cell lymphoma
June 20, 2025 | Poster
Safety and Efficacy of AZD0486, a CD19xCD3 T-cell Engager, in Relapsed or Refractory Diffuse Large B-cell Lymphoma
June 3, 2025 | Poster
Circulating tumor DNA assessment in patients with early-stage classical Hodgkin lymphoma treated with combination of brentuximab vedotin and nivolumab
June 3, 2025 | Poster
ALPHA3: A Pivotal Phase 2 Study of First‑Line (1L) Consolidation With Cemacabtagene Ansegedleucel (Cema‑Cel) in Patients (Pts) With Large B‑Cell Lymphoma (LBCL) and Minimal Residual Disease (MRD) After Response to Standard Therapy
June 3, 2025 | Poster
Sequencing-guided cHemotherapy Optimization Using Real-Time Evaluation in NewlyDiagnosed DLBCL With Circulating Tumor DNA: SHORTEN-ctDNA (NCT06693830)
June 3, 2025 | Poster